US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Ophthalmology Market Research Reports & Industry Analysis

A portion of ophthalmology that resists change unlike some other specialties is the consumer reluctance to undertake a procedure that may have side effects associated with vision like refractive laser correction. Any side effects concerning eyes/vision is typically avoided as much as possible especially if there are other options.
Typically if the out-of pocket price for a life-enhancing procedure is within the budget of a consumer, the patient has a strong desire to get the procedure, and other factors are present that allow for it, the procedure is undertaken. In laser correction there has been skepticism which has diminished as more patients undertake the procedure with good results. While new ideas, breakthrough technologies, cost efficiencies, increased productivity,and new markets are the keys to growth and competitiveness, most people [work force; consumers; academics; politicians] are more confident in familiar environments. They will resist change unless their job, livelihood, or lifestyles are threatened.

This phenomenon is partly responsible for the trend toward closing solo and small group practices to join vision care networks. Though this experience exists more in general medical practices and some pecialties, ophthalmologists also face the threat of practitioners [osteopathic physicians, doctors of optometry] replacing eye MDs—an intrusion on their medical training, skills, and specialty. However increasing healthcare costs, and economic changes sometimes force shifts in the typical work pattern of healthcare providers. One example is a change that has happened in states across the U.S. allowing optometrists to diagnose and treat glaucoma.

RSS Feeds

Ophthalmology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015
1/21/2015 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Neovascular Glaucoma Global Clinical Trials Review, H1, 2015
1/21/2015 | published by: GlobalData
... information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Keratoconjunctivitis sicca (Dry Eye)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... pipeline drugs and marketed drugs across the Keratoconjunctivitis sicca (Dry Eye). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different ...  |  read more...
USD 2,000
Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Cataract. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Cataract. ...  |  read more...
USD 2,000
Ocular Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Ocular Hypertension. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Ocular Inflammation. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Open-Angle Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Open-Angle Glaucoma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Global CINV DrugsIndustry 2014 Market Research Report
1/20/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the CINV Drugs basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Glaucoma - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... Exudative) Macular Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Glaucoma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Glaucoma. ...  |  read more...
USD 2,000
Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape
1/1/2015 | published by: DelveInsight
... chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Ophthalmology Report provides the target gene name, localization of gene, molecular function of target with ...  |  read more...
USD 3,000
Global Tonometer Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Tonometer basic information including Tonometer definition, classification, application and industry chain overview; ...  |  read more...
USD 2,850
Manufacturing Opticians (UK) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 210 largest Manufacturing Opticians (UK) companies. The Manufacturing Opticians (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... Patient Flow Analysis - 2015’. The report provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for top seven pharmaceutical markets. The study measures key indicators ...  |  read more...
USD 1,200
Retinal Degeneration - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Perimetry Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introducedPeripheral Vascular Stents basic information includingPeripheral Vascular Stents definition, classification, application and ...  |  read more...
USD 2,850
Corneal Ulcers - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Glaucoma Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... report provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucoma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Glaucoma derived from epidemiological analysis, percentage of patients ...  |  read more...
USD 1,200
Cataract - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Ophthalmics Partnering Terms & Agreements
12/1/2014 | published by: Current Partnering
... or development stage whereby the licensee obtains a right or an option right to license the licensors ophthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report ...  |  read more...
USD 1,995
Global and Chinese Vision Screeners Industry, 2009-2019 Market Research Report
9/17/2014 | published by: Prof-Research
... report provides key statistics on the market status of the Vision Screeners manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a ...  |  read more...
USD 2,800
Age-related Macular Degeneration Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... age-related macular degeneration partnering deals Top age-related macular degeneration deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Age-related Macular Degeneration Partnering 2009-2014 provides understanding and access to the ...  |  read more...
USD 695
Glaucoma Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Glaucoma Partnering 2009-2014 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
< prev 1    3  4  5  6  7  8  9  10